Search
Mira Pharmaceuticals Inc
MIRAAdd to Watchlist
0.703USD
-0.007-0.99%
Close 10-08 16:00（ET）
29.54MMarket Cap
LossP/E TTM
Mira Pharmaceuticals Inc (MIRA) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Mira Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
3.500USD+379.39%
MIRA Analyst Recommendation Trends
In the current month, MIRA has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MIRA average Analyst price target in the last month is 3.500.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
MIRA Analyst Rating for Peer Comparison
Updated: Oct 8, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
18
0
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Revolution Medicines Inc
RVMD
8
14
1
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-0.15
-0.03
-0.03
Surprise
--
--
--
FAQs
What is Mira Pharmaceuticals Inc's price target?
Analysts forecast that Mira Pharmaceuticals Inc's price target is USD 3.50, with the highest forecast at USD 3.50 and the lowest forecast at USD 3.50.
What is the analyst rating for Mira Pharmaceuticals Inc?
Based on the ratings of Mira Pharmaceuticals Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.